When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?

por Alkhawajah, Mona, Oger, Joel
Publicado 2011

Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies

por Frykman, Hans, Kumar, Pankaj, Oger, Joel
Publicado 2020

Evidence for a two-stage disability progression in multiple sclerosis

por Leray, Emmanuelle, Yaouanq, Jacqueline, Le Page, Emmanuelle, Coustans, Marc, Laplaud, David, Oger, Joël, Edan, Gilles
Publicado 2010

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model

por Palace, Jacqueline, Bregenzer, Thomas, Tremlett, Helen, Oger, Joel, Zhu, Fheng, Boggild, Mike, Duddy, Martin, Dobson, Charles
Publicado 2014

A longitudinal model for disease progression was developed and applied to multiple sclerosis

por Lawton, Michael, Tilling, Kate, Robertson, Neil, Tremlett, Helen, Zhu, Feng, Harding, Katharine, Oger, Joel, Ben-Shlomo, Yoav
Publicado 2015

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

por Shirani, Afsaneh, Zhao, Yinshan, Petkau, John, Gustafson, Paul, Karim, Mohammad Ehsanul, Evans, Charity, Kingwell, Elaine, van der Kop, Mia L., Oger, Joel, Tremlett, Helen
Publicado 2015

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study

por Goodin, Douglas S, Ebers, George C, Cutter, Gary, Cook, Stuart D, O'Donnell, Timothy, Reder, Anthony T, Kremenchutzky, Marcelo, Oger, Joel, Rametta, Mark, Beckmann, Karola, Knappertz, Volker
Publicado 2012

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

por Palace, Jacqueline, Duddy, Martin, Lawton, Michael, Bregenzer, Thomas, Zhu, Feng, Boggild, Mike, Piske, Benjamin, Robertson, Neil P, Oger, Joel, Tremlett, Helen, Tilling, Kate, Ben-Shlomo, Yoav, Lilford, Richard, Dobson, Charles
Publicado 2019

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

por Green, Joshua D, Barohn, Richard J, Bartoccion, Emanuela, Benatar, Michael, Blackmore, Derrick, Chaudhry, Vinay, Chopra, Manisha, Corse, Andrea, Dimachkie, Mazen M, Evoli, Amelia, Florence, Julaine, Freimer, Miriam, Howard, James F, Jiwa, Theresa, Kaminski, Henry J, Kissel, John T, Koopman, Wilma J, Lipscomb, Bernadette, Maestri, Michelanglo, Marino, Mariapaola, Massey, Janice M, McVey, April, Mezei, Michelle M, Muppidi, Srikanth, Nicolle, Michael W, Oger, Joel, Pascuzzi, Robert M, Pasnoor, Mamatha, Pestronk, Alan, Provenzano, Carlo, Ricciardi, Roberta, Richman, David P, Rowin, Julie, Sanders, Donald B, Siddiqi, Zaeem, Soloway, Aimee, Wolfe, Gil I, Wulf, Charlie, Drachman, Daniel B, Traynor, Bryan J
Publicado 2020